Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma-Reference-Cited by-同舟云学术

Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma

Published:2021-09-03 Issue:35 Volume:100 Page:e27100
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Dalong,Li Yingci,Chen Xiaolin,Li Ping

Funder

The innovation fund of Harbin medical university

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers;Conde;Clin Transl Oncol,2013

3. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer;Hicks;J Nucl Med,2001

4. The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment;Hoekstra;Lung Cancer (Amsterdam, Netherlands),2003

5. Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma;Hsu;Nucl Med Commun,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy;Nuclear Medicine Communications;2023-07-31

2. Determination of diagnostic and predictive parameters for vertical mandibular invasion in patients with lower gingival squamous cell carcinoma: A retrospective study;Medicine;2022-12-09

3. Prognostic value of 18F-FDG PET/CT in patients with advanced or metastatic non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Frontiers in Immunology;2022-11-17

4. The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer;Clinical Imaging;2022-09